LogicBio Therapeutics (LOGC) Short Interest Ratio & Short Volume → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free LOGC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis LogicBio Therapeutics Short Interest DataCurrent Short Volume274,400 sharesPrevious Short Volume133,900 sharesChange Vs. Previous Month+104.93%Dollar Volume Sold Short$562,520.00Short Interest Ratio / Days to Cover0.5Last Record DateOctober 31, 2022Outstanding Shares32,963,000 sharesFloat Size21,560,000 sharesShort Percent of Float1.27%Today's Trading Volume0 sharesAverage Trading Volume652,526 sharesToday's Volume Vs. Average0% Short Selling LogicBio Therapeutics ? Sign up to receive the latest short interest report for LogicBio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLOGC Short Interest Over TimeLOGC Days to Cover Over TimeLOGC Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now LogicBio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2022274,400 shares $562,520.00 +104.9%1.3%0.5 $2.05 10/15/2022133,900 shares $274,495.00 +159.5%0.7%0.3 $2.05 9/30/202251,600 shares $14,061.00 +77.3%0.3%0.1 $0.27 9/15/202229,100 shares $10,912.50 -61.1%0.2%0.2 $0.38 8/31/202274,800 shares $26,808.32 -2.7%0.4%0.4 $0.36 8/15/202276,900 shares $39,603.50 +18.7%0.4%0.3 $0.52 Get the Latest News and Ratings for LOGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LogicBio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202264,800 shares $25,434.00 -8.7%0.4%0.1 $0.39 7/15/202271,000 shares $27,690.00 +110.7%0.4%0.1 $0.39 6/30/202233,700 shares $11,795.00 -75.8%0.2%0 $0.35 6/15/2022139,100 shares $60,508.50 -37.6%0.8%0.1 $0.44 5/31/2022222,800 shares $111,400.00 -57.6%1.2%0.2 $0.50 5/15/2022526,000 shares $226,180.00 +952.0%2.9%0.4 $0.43 4/30/202250,000 shares $22,000.00 -60.9%0.3%0 $0.44 4/15/2022127,800 shares $86,137.20 -0.1%0.7%0.4 $0.67 3/31/2022127,900 shares $86,984.79 -10.0%0.7%0.4 $0.68 3/15/2022142,100 shares $99,185.80 -11.9%0.8%0.4 $0.70 2/28/2022161,200 shares $106,392.00 -39.3%0.9%0.5 $0.66 2/15/2022265,500 shares $196,470.00 +60.0%1.5%0.9 $0.74 1/31/2022165,900 shares $248,850.00 -5.8%0.9%0.6 $1.50 1/15/2022176,100 shares $343,395.00 -4.3%1.4%1.9 $1.95 12/31/2021184,000 shares $425,040.00 -31.6%1.4%1.9 $2.31 12/15/2021268,800 shares $658,560.00 -55.0%2.1%2.8 $2.45 11/30/2021597,600 shares $1.79 million -0.5%4.8%7.5 $3.00 11/15/2021600,300 shares $2.11 million -0.7%4.8%7.4 $3.52 10/29/2021604,200 shares $2.21 million +0.8%4.9%7.6 $3.65 10/15/2021599,700 shares $2.40 million +1.9%4.9%7.1 $4.00 9/30/2021588,400 shares $2.69 million +1.9%4.8%6.7 $4.58 9/15/2021577,200 shares $2.61 million +2.2%4.7%4.3 $4.53 8/31/2021564,900 shares $2.68 million -17.3%4.6%3.5 $4.74 8/13/2021682,800 shares $3.08 million -1.9%5.6%3.9 $4.51 7/30/2021696,300 shares $2.90 million -4.0%5.7%3.8 $4.17 7/15/2021724,900 shares $2.79 million -1.2%4.0%3.6 $3.85 6/30/2021733,500 shares $3.26 million -31.5%4.1%3.7 $4.44 6/15/20211,070,000 shares $4.74 million +5.9%6.0%6.5 $4.43 5/28/20211,010,000 shares $4.41 million -2.9%5.6%7.1 $4.37 5/14/20211,040,000 shares $4.61 million +8.4%5.8%7.7 $4.43 4/30/2021959,800 shares $5.49 million +13.4%5.4%7 $5.72 4/15/2021846,200 shares $5.68 million +1.6%4.7%6.5 $6.71 3/31/2021832,900 shares $5.66 million +1.0%4.7%6.5 $6.80 3/15/2021824,400 shares $6.73 million -0.4%4.6%5.9 $8.16The only AI company you should be looking at (Ad)This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.Get the stock ticker here >>> LOGC Short Interest - Frequently Asked Questions What is LogicBio Therapeutics' current short interest? Short interest is the volume of LogicBio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 274,400 shares of LOGC short. 1.27% of LogicBio Therapeutics' shares are currently sold short. Learn More on LogicBio Therapeutics' current short interest. What is a good short interest percentage for LogicBio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.27% of LogicBio Therapeutics' floating shares are currently sold short. Is LogicBio Therapeutics' short interest increasing or decreasing? LogicBio Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 274,400 shares, an increase of 104.9% from the previous total of 133,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is LogicBio Therapeutics' float size? LogicBio Therapeutics currently has issued a total of 32,963,000 shares. Some of LogicBio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LogicBio Therapeutics currently has a public float of 21,560,000 shares. How does LogicBio Therapeutics' short interest compare to its competitors? 1.27% of LogicBio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to LogicBio Therapeutics: Ikena Oncology, Inc. (3.87%), Turnstone Biologics Corp. (2.73%), Elutia Inc. (0.19%), Aligos Therapeutics, Inc. (0.49%), Atara Biotherapeutics, Inc. (9.95%), Semper Paratus Acquisition Co. (0.25%), Cidara Therapeutics, Inc. (0.24%), Passage Bio, Inc. (1.51%), Cognition Therapeutics, Inc. (0.58%), Curis, Inc. (1.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.81 billion), Charter Communications, Inc. ($3.04 billion), T. Rowe Price Group, Inc. ($1.98 billion), PG&E Co. ($1.92 billion), Lucid Group, Inc. ($1.90 billion), Coinbase Global, Inc. ($1.75 billion), Roblox Co. ($1.58 billion), Rivian Automotive, Inc. ($1.54 billion), Diamondback Energy, Inc. ($1.53 billion), and Old Dominion Freight Line, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short LogicBio Therapeutics stock? Short selling LOGC is an investing strategy that aims to generate trading profit from LogicBio Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LogicBio Therapeutics? A short squeeze for LogicBio Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LOGC, which in turn drives the price of the stock up even further. How often is LogicBio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LOGC, twice per month. The most recent reporting period available is October, 31 2022. More Short Interest Resources from MarketBeat Related Companies: IKNA Short Squeeze TSBX Short Squeeze ELUT Short Squeeze ALGS Short Squeeze ATRA Short Squeeze LGST Short Squeeze CDTX Short Squeeze PASG Short Squeeze CGTX Short Squeeze CRIS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LOGC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company